Trials / Withdrawn
WithdrawnNCT04308551
Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease
Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Stable Coronary Heart Disease. A Prospective, Randomized and Controlled，Single Blind, Single-center, Opening Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Henan Institute of Cardiovascular Epidemiology · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effect of Indobufen and Aspirin on platelet aggregation and long term prognosis in patients with stable coronary heart disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indobufen | Indobufen Tablets |
| DRUG | Aspirin | Aspirin Tablets |
Timeline
- Start date
- 2024-12-30
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
- First posted
- 2020-03-16
- Last updated
- 2024-11-20
Source: ClinicalTrials.gov record NCT04308551. Inclusion in this directory is not an endorsement.